ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 19,972 | 19,516 | 18,799 | 21,037 | 17,387 |
| Cost of Goods | 3,260 | 3,141 | 2,751 | 3,673 | 3,061 |
| Gross Profit | 16,712 | 16,375 | 16,048 | 17,364 | 14,326 |
| Operating Expenses | 8,521 | 8,102 | 7,232 | 7,265 | 6,188 |
| Operating Income | 8,451 | 8,414 | 9,567 | 10,772 | 8,199 |
| Interest Expense | 2,766 | 2,749 | 2,725 | 800 | -10 |
| Other Income | -28 | 0 | 68 | 88 | 82 |
| Pre-tax Income | 5,657 | 5,665 | 6,910 | 10,060 | 8,291 |
| Income Tax | 1,098 | 2,094 | 2,541 | -10,945 | 1,545 |
| Net Income Continuous | 4,559 | 3,571 | 4,369 | 21,005 | 6,746 |
| Net Income | $4,559 | $3,571 | $4,369 | $21,005 | $6,746 |
| EPS Basic Total Ops | 0.40 | 0.31 | 0.38 | 1.90 | 0.59 |
| EPS Basic Continuous Ops | 0.40 | 0.31 | 0.39 | 1.90 | 0.60 |
| EPS Diluted Total Ops | 0.39 | 0.31 | 0.38 | 1.88 | 0.59 |
| EPS Diluted Continuous Ops | 0.39 | 0.31 | 0.38 | 1.88 | 0.60 |
| EBITDA(a) | $10,498 | $9,829 | $10,894 | $12,054 | $9,386 |